These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 16088801)
1. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. Kapikian AZ; Simonsen L; Vesikari T; Hoshino Y; Morens DM; Chanock RM; La Montagne JR; Murphy BR J Infect Dis; 2005 Sep; 192 Suppl 1():S22-9. PubMed ID: 16088801 [TBL] [Abstract][Full Text] [Related]
2. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants. Clark HF; Offit PA; Plotkin SA; Heaton PM Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425 [TBL] [Abstract][Full Text] [Related]
3. Rotavirus vaccines: entering a new stage of deployment. Nakagomi O; Cunliffe NA Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784 [TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486 [TBL] [Abstract][Full Text] [Related]
6. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901 [TBL] [Abstract][Full Text] [Related]
8. Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization. Hoshino Y; Jones RW; Ross J; Kapikian AZ Vaccine; 2005 May; 23(29):3791-9. PubMed ID: 15893616 [TBL] [Abstract][Full Text] [Related]
9. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194 [TBL] [Abstract][Full Text] [Related]
10. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants. Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513 [TBL] [Abstract][Full Text] [Related]
11. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq. Ciarlet M; Schödel F Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144 [TBL] [Abstract][Full Text] [Related]
12. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. ; Pediatrics; 2009 May; 123(5):1412-20. PubMed ID: 19332437 [TBL] [Abstract][Full Text] [Related]
13. Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Heaton PM; Ciarlet M Clin Infect Dis; 2007 Dec; 45(12):1618-24. PubMed ID: 18198497 [TBL] [Abstract][Full Text] [Related]
14. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule? Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses. Goveia MG; Suprun L; Itzler RF; McFetridge R; Dallas MJ; Kuter BJ Pediatr Infect Dis J; 2010 Mar; 29(3):263-5. PubMed ID: 19949360 [TBL] [Abstract][Full Text] [Related]
17. [Rotaviruses in human and veterinary medicine]. Dodet B; Heseltine E; Mary C; Saliou P Sante; 1997; 7(3):195-9. PubMed ID: 9296811 [TBL] [Abstract][Full Text] [Related]
18. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity. Hoshino Y; Jones RW; Chanock RM; Kapikian AZ J Med Virol; 1997 Apr; 51(4):319-25. PubMed ID: 9093947 [TBL] [Abstract][Full Text] [Related]
19. RotaTeq: Progress toward developing world access. Goveia MG; Nelson CB; Ciarlet M J Infect Dis; 2010 Sep; 202 Suppl():S87-92. PubMed ID: 20684723 [TBL] [Abstract][Full Text] [Related]
20. Development of candidate rotavirus vaccines derived from neonatal strains in India. Glass RI; Bhan MK; Ray P; Bahl R; Parashar UD; Greenberg H; Rao CD; Bhandari N; Maldonado Y; Ward RL; Bernstein DI; Gentsch JR J Infect Dis; 2005 Sep; 192 Suppl 1():S30-5. PubMed ID: 16088802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]